Efficacy and Safety of Bevacizumab in Patients with Low-Grade Serous Ovarian Cancer-Reference-Cited by-同舟云学术

Efficacy and Safety of Bevacizumab in Patients with Low-Grade Serous Ovarian Cancer

Published:2024-02 Issue:4 Volume:20 Page:207-214
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncol.

Author:

Karacin Cengiz¹^ORCID,Sunar Veli²,Urakci Zuhat³^ORCID,Yilmaz Ali⁴,Ayhan Murat⁵,Ersoy Mustafa⁶,Guven Deniz Can⁷^ORCID,Erturk Ismail⁸,Durmus Yasin⁹,Karacin Pinar⁹,Boran Nurettin⁹,Ustun Yaprak Engin⁹,Meydan Mutlu¹⁰,Dogan Mutlu¹^ORCID,Oksuzoğlu Berna¹,Ates Ozturk¹,Karaca Mustafa¹¹,Uncu Dogan¹²,Ergun Yakup¹³^ORCID,Arik Zafer⁷

Affiliation:

1. Department of Medical Oncology, University of Health Sciences, Dr Abdurrahman Yurtaslan Ankara Oncology Training & Research Hospital, Ankara, Turkey

2. Depatment of Medical Oncology, Losante Children & Adult Hospital, Ankara, Turkey

3. Departmen of Medical Oncology, Dicle University, Diyarbakir, Turkey

4. Department of Medical Oncology, Atatürk University Training Hospital, Erzurum, Turkey

5. Department of Medical Oncology, Kartal Training & Research Hospital, Istanbul, Turkey

6. Department of Medical Oncology, Osmangazi University, Eskisehir, Turkey

7. Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey

8. Department of Medical Oncology, University of Health Sciences, Gulhane Training & Research Hospital, Ankara, Turkey

9. Department of Gynecology, Etlik Zubeyde Hanim Training & Research Hospital, Ankara, Turkey

10. Department of Gynecology, Zekai Tahir Burak Training & Research Hospital, Ankara, Turkey

11. Department of Medical Oncology, Antalya Training & Research Hospital, Antalya, Turkey

12. Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Turkey

13. Department of Medical Oncology, Antalya City Hospital, Antalya, Turkey

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/fon-2023-0763

Reference25 articles.

1. Advancements in Low-Grade Serous Carcinoma of the Ovary and Peritoneum

2. Molecular characteristics and clinical behaviour of epithelial ovarian cancers

3. Low-Grade Serous Carcinoma of the Ovary: The Current Status

4. Low grade serous ovarian cancer – A rare disease with increasing therapeutic options

5. MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma